Recruiting studies: Tamsulosin

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Real World Study in Greek Patients with BPH for Disease Control and QoL Under FDC Treatment with Solifenacin/Tamsulosin.
Phase N/A · 6 location(s) · Elpen Pharmaceutical Co. Inc. · NCT06528613 L-Citrulline Versus Tamsulosin for Medical Expulsive Therapy of Distal Ureteral Stones
Phase 2 · 1 location(s) · Beni-Suef University · NCT07617909 Efficacy and Safety of Tamsulosin for Children with Posterior Urethral Valve.
Phase 3 · 1 location(s) · Mansoura University · NCT06737016 Post Operative Urinary Retention (POUR) Following Thoracic Oncological Surgery
EARLY_Phase 1 · 4 location(s) · Hackensack Meridian Health · NCT05657990 Tamsulosin Monotherapy Versus Combination Therapy With Tadalafil (2.5 mg vs 5 mg) in Managing Male LUTS Secondary to BPH
NA · 1 location(s) · Ain Shams University · NCT07722884 A Clinical Observation Study of a Chinese Patent Medicine Combined With Tamsulosin in Improving Sleep and Nocturia Sympt
Phase 4 · 1 location(s) · The Fourth Affiliated Hospital of Zhejiang University School · NCT07357324 Comparison of Mirabegron and Tamsulosin for Ureteral Stone Expulsion
Phase 4 · 1 location(s) · Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · NCT07310797 Tamsulosin With or Without Tadalafil for Trial Without Catheter After Acute Urinary Retention Due to Benign Prostatic Hy
Phase 4 · 1 location(s) · Beni-Suef University · NCT07654413 Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery
Phase 2 · 1 location(s) · Allegheny Singer Research Institute (also known as Allegheny · NCT04597372 Study of Tamsulosin, Solifenacin and Mirabegron in Alleviating Ureteral Stent-related Symptoms
Phase 3 · 1 location(s) · Bir Hospital · NCT06803030 A Comparative Bioavailability Study of Tamsulosin 0.4 mg Prolonged-release Tablets Versus the Reference Drug Omnic Ocas®
Phase 1 · 1 location(s) · Berlin-Chemie AG Menarini Group · NCT07156916 Medications for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia
Phase 3 · 1 location(s) · Tanta University · NCT06491108 Tamsulosin Dose Escalation or Silodosin Switch Before Trial Without Catheter in BPH-Related Acute Urinary Retention
Phase 4 · 1 location(s) · Beni-Suef University · NCT07650968 Safety and Efficacy of Combination of Tamsulosin 0.4 mg Plus Tadalafil 5mg Versus 2.5 mg
NA · 1 location(s) · Ain Shams University · NCT07562282 Tamsulosin and Intraureteral Aminophylline for Ureteral Access During RIRS
Phase 2 · 3 location(s) · Beni-Suef University · NCT07623876 Peri-operative Tamsulosin and Impact on Voiding Trial After Same-day Urogynecology Surgery
Phase 3 · 1 location(s) · TriHealth Inc. · NCT06843538 Comparison of Alpha Blockers (Terazosin and Tamsulosin) in Reducing Ureteral Stent Related Symptoms
Phase 3 · 2 location(s) · Penang Hospital, Malaysia · NCT06966804 Proof-of-concept Study to Evaluate the Safety and Efficacy of Tryptophan in Patients with BPH.
Phase 2 · 1 location(s) · Clinical Academic Center (2CA-Braga) · NCT05401032

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.